Management of stage T1 tumors of the bladder: International consensus panel

被引:169
作者
Nieder, AM
Brausi, M
Lamm, D
O'Donnell, M
Tomita, K
Woo, H
Jewett, MAS
机构
[1] SUNY Stony Brook, Dept Urol, Stony Brook, NY 11794 USA
[2] Estense S Agostino Hosp, Dept Urol, Modena, Italy
[3] BCG Oncol, Dept Urol, Phoenix, AZ USA
[4] Univ Iowa, Dept Urol, Iowa City, IA 52242 USA
[5] Univ Tokyo, Dept Urol, Tokyo 113, Japan
[6] Westmead Hosp, Dept Urol, Westmead, NSW 2145, Australia
[7] Univ Toronto, Princess Margaret Hosp, Univ Hlth Network, Dept Surg Oncol,Div Urol, Toronto, ON, Canada
关键词
D O I
10.1016/j.urology.2005.08.066
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The International Consensus Panel on T1 bladder tumors markers reviewed the subject from a clinical perspective. From diagnosis to treatment decisions, what are the important issues in the management of a new patient? The assessment of prognostic factors for progression requires optimal resection and documentation. The role of immediate adjuvant intravesical chemotherapy after resection remains controversial. How often should the upper tract be assessed for tumor recurrence? The decision on whether to attempt bladder conservation with intravesical therapy or to perform a cystectomy is the most difficult issue in the management of superficial bladder cancer today. Finally, what therapies exist if initial intravesical bacille Calmette-Guerin fails to eradicate the disease or prevent recurrence? The panel thoroughly explored all these subjects and has made recommendations with supporting evidence.
引用
收藏
页码:108 / 125
页数:18
相关论文
共 109 条
[1]   SHOULD PT-1 TRANSITIONAL CELL CANCERS OF THE BLADDER STILL BE CLASSIFIED AS SUPERFICIAL [J].
ABEL, PD ;
HALL, RR ;
WILLIAMS, G .
BRITISH JOURNAL OF UROLOGY, 1988, 62 (03) :235-239
[2]  
ABRAMS P, 2005, INCONTINENCE, V1, P10
[3]   UPPER URINARY-TRACT TRANSITIONAL CELL-CARCINOMA IN PATIENTS WITH BLADDER-CARCINOMA AND ASSOCIATED VESICOURETERAL REFLUX [J].
AMAR, AD ;
DAS, S .
JOURNAL OF UROLOGY, 1985, 133 (03) :468-471
[4]   RADICAL CYSTECTOMY FOR STAGE-TA, STAGE-TIS AND STAGE-T1 TRANSITIONAL-CELL CARCINOMA OF THE BLADDER [J].
AMLING, CL ;
THRASHER, JB ;
FRAZIER, HA ;
DODGE, RK ;
ROBERTSON, JE ;
PAULSON, DF .
JOURNAL OF UROLOGY, 1994, 151 (01) :31-36
[5]  
AYALA EP, 2001, ARCH ESP UROL, V54, P211
[6]  
Ayed M, 1998, Prog Urol, V8, P206
[7]   Intravesical bacillus Calmette-Guerin treatment for stage T1 grade 3 transitional cell carcinoma of the bladder [J].
Baniel, J ;
Grauss, D ;
Engelstein, D ;
Sella, A .
UROLOGY, 1998, 52 (05) :785-789
[8]   Superficial bladder cancer:: The role of interferon-α [J].
Belldegrun, AS ;
Franklin, JR ;
O'Donnell, MA ;
Gomella, LG ;
Klein, E ;
Neri, R ;
Nseyo, UO ;
Ratliff, TL ;
Williams, RD .
JOURNAL OF UROLOGY, 1998, 159 (06) :1793-1801
[9]   Photodynamic therapy with intravesical instillation of 5-aminolevulinic acid for patients with recurrent superficial bladder cancer: a single-center study [J].
Berger, AP ;
Steiner, H ;
Stenzl, A ;
Akkad, T ;
Bartsch, G ;
Holtl, L .
UROLOGY, 2003, 61 (02) :338-341
[10]   Management of clinical T1 bladder transitional cell carcinoma by radical cystectomy [J].
Bianco, FJ ;
Justa, D ;
Grignon, DJ ;
Sakr, WA ;
Pontes, JE ;
Wood, DP .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2004, 22 (04) :290-294